Saskia A C Luelmo

6PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ReproductionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 06, 2022
Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.

Derk C F Klatte, Bas Boekestijn, Martin N J M Wasser

|Jan 27, 2022
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Eva Versteijne, Jacob L van Dam, Mustafa Suker

|Jan 27, 2022
The prognostic value of the 12-, 6-, 3- and 1-month 'Surprise Question' in cancer patients: A prospective cohort study in three hospitals.

Arianne Stoppelenburg, Müzeyyen Arslan, Catherine Owusuaa

|Aug 23, 2021
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

Fleur van der Sijde, Zakia Azmani, Marc G Besselink

|Feb 12, 2020
Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies.

F J Sherida H Woei-A-Jin, Shu Zhen Zheng, Inci Kiliçsoy

Pageof 1